Peptide Report
Source-backed explainers, regulatory tracking, and research notes for readers trying to make sense of the peptide conversation.
BPC-157
Regulatory Watch
BPC-157 is widely discussed online in injury recovery and performance communities, but the public evidence and regulatory posture require careful separation from social-media claims.
Popular YouTube shows can flag what readers are hearing. We track them as media signals, then verify claims against primary sources before updating guides.
Retatrutide
Long-form doctor-led retatrutide discussion with monitoring, diet, exercise, and supplement chapters that may shape reader search behavior.
13K views · 57 comments · 54K subscribers · checked Jun 30, 2026
Track as a media signal; do not convert the episode into treatment, dosing, or purchasing guidance.
Retatrutide
High-view retatrutide explainer using strong outcome language; useful for identifying claims that need careful source separation.
615K views · 1.2K comments · 224K subscribers · checked Jun 30, 2026
Check claims against primary regulatory and trial sources before any page update.
Peptide science and safety
Large-audience peptide safety conversation that can influence mainstream questions and category-level search demand.
416K views · 1K comments · 7.6M subscribers · checked Jun 30, 2026
Use only to identify questions and themes; cite primary sources for factual claims.
Retatrutide
Another long-form retatrutide masterclass format that helps compare recurring claims and audience questions.
200K views · 665 comments · 390K subscribers · checked Jun 30, 2026
Treat as a discovery source for public questions, not as evidence.
Starting points for source-backed peptide research. These are editorial guide queues, not purchasing recommendations.
A ranked starting point for the pages most likely to need regulatory or source updates.
See guideThe peptide guides currently anchored by FDA advisory and risk-source records.
See guidePlain-English explainers that separate online claims from reviewed sources.
See guideHow the site keeps claims, citations, analytics, and review dates in one loop.
See guide
DSIP
Regulatory Watch
DSIP appears in online sleep and recovery discussions. This page tracks the topic as a source-backed index entry pending deeper evidence review.
Epitalon
Regulatory Watch
Epitalon is often discussed in longevity-oriented peptide content. The page starts as a regulatory watch entry and should be expanded only after source review.
GHK-Cu
Evidence Guide
GHK-Cu is discussed in skincare, cosmetic, and broader peptide contexts. This page separates cosmetic discussion from medical or systemic claims.
KPV
Regulatory Watch
KPV is a peptide topic appearing in online wellness and research discussions. This page tracks the public source record and keeps claims separated from treatment language.
Browse the current peptide explainers by topic, status, and review depth.
DSIP
Regulatory Watch
DSIP appears in online sleep and recovery discussions. This page tracks the topic as a source-backed index entry pending deeper evidence review.
Epitalon
Regulatory Watch
Epitalon is often discussed in longevity-oriented peptide content. The page starts as a regulatory watch entry and should be expanded only after source review.
GHK-Cu
Evidence Guide
GHK-Cu is discussed in skincare, cosmetic, and broader peptide contexts. This page separates cosmetic discussion from medical or systemic claims.
KPV
Regulatory Watch
KPV is a peptide topic appearing in online wellness and research discussions. This page tracks the public source record and keeps claims separated from treatment language.
MOTS-c
Regulatory Watch
MOTS-c is a peptide topic commonly associated with metabolic and longevity discussions online. This starter page keeps the topic in the review queue without endorsing those claims.
Retatrutide
Regulatory Watch
Retatrutide is an investigational triple-agonist peptide (GLP-1, GIP, and glucagon receptor agonist) developed by Eli Lilly that showed significant weight loss in Phase 2 clinical trials. It is not FDA-approved for any indication. The peptide has received high online attention from biohacking and fitness communities, requiring careful separation of clinical trial data from social media claims.
Latest Guides
| Topic | Status | Claims | Sources | Next review |
|---|---|---|---|---|
| BPC-157 | Regulatory watch | 2 | 3 | 2026-07-24 |
| DSIP | Regulatory watch | 1 | 2 | 2026-07-24 |
| Epitalon | Regulatory watch | 1 | 2 | 2026-07-24 |
| GHK-Cu | Evidence review | 1 | 1 | 2026-07-30 |
| KPV | Regulatory watch | 1 | 2 | 2026-07-24 |
| MOTS-c | Regulatory watch | 1 | 2 | 2026-07-24 |
| Retatrutide | Regulatory watch | 4 | 6 | 2026-07-29 |
| Semax | Regulatory watch | 1 | 2 | 2026-07-24 |
| TB-500 | Regulatory watch | 2 | 2 | 2026-07-24 |